(Q53475411)

14 May 2018

title

Intensive insulin therapy in newly diagnosed type 2 diabetes. (English)

1 reference

14 May 2018

0 references

1 reference

1 reference

2

Daniel J Drucker

1 reference

14 May 2018

author name string

Ravi Retnakaran

series ordinal

1

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 May 2008

1 reference

14 May 2018

published in

The Lancet

1 reference

14 May 2018

volume

371

1 reference

14 May 2018

issue

9626

1 reference

14 May 2018

page(s)

1725-1726

1 reference

14 May 2018

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

Short-term intensive insulin therapy in newly diagnosed type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960736-9

7 January 2021

10.1016/S0140-6736(08)60736-9

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

18502278

1 reference

14 May 2018